期刊文献+

血浆尾加压素Ⅱ水平与高血压左心室肥厚的相关性分析 被引量:4

下载PDF
导出
摘要 目的探讨原发性高血压血浆尾加压素Ⅱ(U-Ⅱ)水平与左心室肥厚(LVH)的关系。方法选取我院高血压门诊原发性高血压患者106例,应用心脏彩色超声心动图检测患者左心室质量指数(LVMI),根据左心室质量指数将高血压患者分为高血压伴左心室肥厚组(EH-LVH)和高血压非左室肥厚组(EH-NLVH),采用放射免疫法检测血浆U-Ⅱ水平。同时选择同期健康体检者50例作为正常对照组。结果 EH-LVH组血浆U-Ⅱ水平(4.8±1.5)μmol/L,明显高于正常对照组(2.0±1.3)μmol/L,差异有统计学意义(P<0.05)。EH-NLVH组(1.8±1.6)μmol/L,与正常对照组比较差异无统计学意义(P>0.05)。直线相关分析显示血浆U-Ⅱ水平与LVMI呈正相关(r=0.518,P<0.01)。结论血浆U-Ⅱ水平与高血压合并左心室肥厚显著相关,血浆U-Ⅱ可能是高血压左心室肥厚疾病发生发展的主要因素之一。
出处 《中国实用神经疾病杂志》 2011年第23期53-54,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献6

二级参考文献7

  • 1Laviades C,Varo N,Diez J,et al.Transforming growth factor-β in hypertensives with cardiorenal damage[J].Hypertension,2000,36(5):517-525.
  • 2Hofmann MA,Drury S,Hudson BI,et al.RAGE and arthritis:the G82S polymorphism amplifies the lammatory response[J].Genes Immun,2002,3:123-135.
  • 3Poirier O,Nicaud V,Vionnet N,er al.Polymorphism screening of four genes encoding advanced glycation end product putative receptors.Association study with nephropathy in type 1 diabetic patients[J].Diaberts,2001,50(5):1 214-1 218.
  • 4Harashima A,Yamamoto Y,Cheng C.et al.Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end products:structure,function and expression[J].Biochem J,2006,396:109-115.
  • 5Koyama H,Shoji T,Fukumoto S,et al.Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease[J].Arterioscler Thromb Vasc Biol,2007,27:147-153.
  • 6张克巨,李莉,崔天祥.高血压合并左室肥厚患者晚期糖基化产物与血管紧张素Ⅱ的相关性研究[J].中国实用神经疾病杂志,2010,13(3):21-23. 被引量:4
  • 7陈亚红,赵鸣武,姚婉贞,庞永政,唐朝枢.The signal transduction pathway in the proliferation of airway smooth muscle cells induced by urotensin Ⅱ[J].Chinese Medical Journal,2004(1):37-41. 被引量:15

共引文献7

同被引文献33

  • 1郭纪群,贾恩志,杨志健.吸烟与冠状动脉粥样硬化程度关系的研究[J].南京医科大学学报(自然科学版),2007,27(10):1187-1192. 被引量:16
  • 2Xu S,Jiang H,Wu B,et a l .Urotensin II induces migration o fcndothc-lial progenitor cells via activation of the RhoA/Rho kinase pathway [J].Tnhoku J Exp Med,2009;219(4):283-288.
  • 3Manzano L, Garcla-Diaz J D, G6mez-Cerezo J, et al. Clinical value of the ankle-brachial index in patients at risk of cardiovascular disease but without known atherothrombotic disease: VITAMIN study [J].Rev Esp Cardiol, 2006 , 59 ( 7 ) : 662-670.
  • 4Xu S, Jiang H, Wu B, et al.Urotensin II induces migration of endothe-lial progenitor cells via activation of the RhoA/Rho kinase pathway [J].Tohoku J Exp Med, 2009, 219 ( 4 ) : 283-288.
  • 5何光朝,郭纪群.葛均波.血脂各成分及其比值与冠状动脉粥样硬化程度的关系[J].中华临床医师杂志(电子版),2013.7(16):7427-7431.
  • 6Hamood Al Kindi,Anouar Hafiane,Zhipeng You,et al .Circulatinglevels of the vasoactive peptide urotensin Ⅱ in patients withacute coronary syndrome and stable coronary artery disease[J].Peptides,2014,1(7):98-105.
  • 7Bai XY,Liu XC,Yang Q,et al .The interaction between humanurotensin Ⅱ and vasodilator agents in human internal mammaryartery with possible clinical implications[J].The Annals of ThoracicSurgery,2011,92 (2):-616.
  • 8Wojciech JR,Beng LC,John ET,et al .Human urotensin Ⅱ inducedaortaring contractions are mediated by protein kinase C,tyrosine kinases and Rho kinase:inhibition by somatostatin receptorantagonists[J].European Journal of Pharmacology,2012,438(3):159-170.
  • 9Watson A,MOlukman M,C Koulis C,et al .Urotensin Ⅱ receptorantagonism confers vasoprotective effects in diabetes associatedatherosclerosis:studies in humans and in a mouse model ofdiabetes[J].Diabetologia,2013,56(5):1155-1165.
  • 10张丽芳,陈莉,丁文惠,史力斌,柯元南.血浆尾加压素Ⅱ浓度与冠状动脉病变程度的关系[J].中日友好医院学报,2008,22(1):3-6. 被引量:10

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部